Navigation path

EU R&I, Better Health for All

World Malaria Day: EU Research

According to the World Health Organisation, in 2010, an estimated 219 million malaria cases occurred globally and the disease killed about 660 000 people, mostly children under five years of age.

Since 2002, the EU has invested more than €209 million in 87 projects carrying out research into the disease and how to control it. In addition, through its partnership with sub-Saharan Africa (the EDCTP initiative), the EU is supporting 32 clinical trials into new treatments with some €50 million.

Thanks to the efforts of the EU and international community, as well as governments and health-care providers in endemic countries, malaria deaths have fallen by 25% since the year 2000.

Press release: EU research project develops new malaria test tool

More background information: Contribution of EU research to fight against Malaria

Here are two examples of successful, EU-funded malaria-related research projects:

Picture of collecting blood from patient

Fast, accurate and cost-effective test to help eradicate malaria

EU-funded researchers are developing a highly accurate, cost-effective and simple-to-use test for malaria. The innovative diagnostic tool, which is being refined and tested in Africa and Asia, promises to save lives through early detection while advancing efforts to eradicate the deadly mosquito-borne disease.

Image of dead tiger mosquito

A big booster for vaccine development

An EU-funded project has accelerated the development of vaccines for diseases such as Lyme disease, malaria, tuberculosis, dengue, influenza, mumps, whooping cough, pneumonia, HIV, and two types of cancer. Their work could lead to new, more effective vaccines - potentially saving millions of people from disease.

 

For more information: